Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients. Int J Res Pharm Hos & Clin. Pharm. 2019;2(1):1-4. Accessed April 3, 2026. https://www.rubatosis.org/journals/index.php/ijrhcp/article/view/144